Oral L-ornithine-L-aspartate improves health-related quality of life in cirrhotic patients with hepatic encephalopathy: an open-label, prospective, multicentre observational study.

Ong, Janus P

Oral L-ornithine-L-aspartate improves health-related quality of life in cirrhotic patients with hepatic encephalopathy: an open-label, prospective, multicentre observational study. [electronic resource] - Clinical drug investigation 2011 - 213-20 p. digital

Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

1173-2563

10.2165/11586700-000000000-00000 doi


Administration, Oral
Adult
Aged
Dipeptides--adverse effects
Female
Hepatic Encephalopathy--drug therapy
Humans
Liver Cirrhosis--complications
Male
Middle Aged
Prospective Studies
Quality of Life